Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (31-40 of 243) with videos related to

Pageof 25
Sort By:
Journal of Neurology|June 20, 2003
Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological diseaseUlrich Herrlinger, Frank Schwärzler, Robert Beck, et al.
Oncology|January 17, 2008
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case seriesMartin Glas, Horst Koch, Birgit Hirschmann, et al.
Journal of Neuropathology and Experimental Neurology|June 14, 2024
FH-mutant glioma displaying the epigenetic signature of IDH-mutant astrocytomasValentina Zschernack, Christian Thomas, Christina Schaub, et al.
Frontiers in Oncology|June 28, 2021
Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in GlioblastomaJohannes Wach, Stefanos Apallas, Matthias Schneider, et al.
Cancers|July 9, 2022
In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission TomographyCristina Barca, Claudia Foray, Bastian Zinnhardt, et al.
Journal of Neuro-Oncology|June 1, 2005
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patientsWilhelm Küker, Thomas Nägele, Agnieska Korfel, et al.
Frontiers in Oncology|March 22, 2021
Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in GlioblastomaJohannes Wach, Stefanos Apallas, Matthias Schneider, et al.
Neuro-Oncology|November 15, 2024
Gene expression signature-defined necroinflammation is not associated with sex-biased survival or bevacizumab benefit in glioblastomaJohannes Weller, Emre Kocakavuk, Barbara Pregler, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 31, 2008
Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitisWilhelm Küker, Susanne Gaertner, Thomas Nagele, et al.
Acta Oncologica (Stockholm, Sweden)|October 16, 2007
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastomaMartin Glas, Burkhard Hennemann, Birgit Hirschmann, et al.
Pageof 25

Showing results (31-40 of 243) with videos related to

Sort By:
Pageof 25
Journal of Neurology|June 20, 2003
Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological diseaseUlrich Herrlinger, Frank Schwärzler, Robert Beck, et al.
Oncology|January 17, 2008
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case seriesMartin Glas, Horst Koch, Birgit Hirschmann, et al.
Journal of Neuropathology and Experimental Neurology|June 14, 2024
FH-mutant glioma displaying the epigenetic signature of IDH-mutant astrocytomasValentina Zschernack, Christian Thomas, Christina Schaub, et al.
Frontiers in Oncology|June 28, 2021
Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in GlioblastomaJohannes Wach, Stefanos Apallas, Matthias Schneider, et al.
Cancers|July 9, 2022
In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission TomographyCristina Barca, Claudia Foray, Bastian Zinnhardt, et al.
Journal of Neuro-Oncology|June 1, 2005
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patientsWilhelm Küker, Thomas Nägele, Agnieska Korfel, et al.
Frontiers in Oncology|March 22, 2021
Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in GlioblastomaJohannes Wach, Stefanos Apallas, Matthias Schneider, et al.
Neuro-Oncology|November 15, 2024
Gene expression signature-defined necroinflammation is not associated with sex-biased survival or bevacizumab benefit in glioblastomaJohannes Weller, Emre Kocakavuk, Barbara Pregler, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 31, 2008
Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitisWilhelm Küker, Susanne Gaertner, Thomas Nagele, et al.
Acta Oncologica (Stockholm, Sweden)|October 16, 2007
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastomaMartin Glas, Burkhard Hennemann, Birgit Hirschmann, et al.
Pageof 25